Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract
Open Access
- 9 October 2008
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 8 (1) , 176
Abstract
Background: The majority of commensal gastrointestinal bacteria used as probiotics are highly adapted to the specialised environment of the large bowel. However, unlike pathogenic bacteria; they are often inadequately equipped to endure the physicochemical stresses of gastrointestinal (GI) delivery in the host. Herein we outline a patho-biotechnology strategy to improve gastric delivery and host adaptation of a probiotic strainBifidobacterium breveUCC2003 and the generally regarded as safe (GRAS) organismLactococcus lactisNZ9000.Results: In vitrobile tolerance of both strains was significantly enhanced (P< 0.001), following heterologous expression of theListeria monocytogenesbile resistance mechanism BilE. Strains harbouringbilEwere also recovered at significantly higher levels (P< 0.001), than control strains from the faeces and intestines of mice (n= 5), following oral inoculation. Furthermore, aB. brevestrain expressingbilEdemonstrated increased efficacy relative to the wild-type strain in reducing oralL. monocytogenesinfection in mice.Conclusion: Collectively the data indicates that bile tolerance can be enhanced inBifidobacteriumandLactococcusspecies through rational genetic manipulation and that this can significantly improve delivery to and colonisation of the GI tract.Keywords
This publication has 35 references indexed in Scilit:
- Engineered pharmabiotics with improved therapeutic potentialHuman Vaccines, 2008
- Designer probiotics: a potential therapeutic for Clostridium difficile?Journal of Medical Microbiology, 2008
- ‘Bioengineered Bugs’ – A patho-biotechnology approach to probiotic research and applicationsMedical Hypotheses, 2008
- New frontiers in probiotic researchLetters in Applied Microbiology, 2007
- Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003Microbiology, 2007
- Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118Proceedings of the National Academy of Sciences, 2007
- Patho-biotechnology: using bad bugs to do good thingsCurrent Opinion in Biotechnology, 2006
- The Probiotic Approach: An Alternative Treatment Option in UrologyEuropean Urology, 2005
- Mutations in the Listerial proB Gene Leading to Proline Overproduction: Effects on Salt Tolerance and Murine InfectionApplied and Environmental Microbiology, 2001
- Quorum sensing-controlled gene expression in lactic acid bacteriaJournal of Biotechnology, 1998